Wednesday, September 17, 2014

Second Question of the Day September 17, 2014 Is Senate Bill 2825 a good idea or a bad idea? What are the pros and cons? What is DEA's position on this one? How would this work with the DQSA if it is a compounded preparation that contains a controlled subtance but pharmacists are mass producing the same preparation and sending it to doctors for specific patient? Is this a way for compounded pain pharmacist and doctors to continue to gain mass profits from illegal compounded pain medications?


No comments: